CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Leigh Peterson

Executive Vice President of Product Development & Xenotransplantation, United Therapeutics

Verified interview transcripts, podcast appearances, and direct quotes from Leigh Peterson, Executive Vice President of Product Development & Xenotransplantation at United Therapeutics. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • United Therapeutics Corporation Q4 2025 Earnings Call

    February 25, 2026 · 📺 i101

    United Therapeutics Corporation Q4 2025 Earnings Conference Call. If you find our work useful, please support us by purchasing a Super Thanks— it truly helps us a lot. #earningscall #StockMarketNews #conferenceCall Earnings Call | Earnings Conference Call | Earnings concall | concall | quarterly results | Stock News | Full Year results | Fiscal Year results | investment news | stock latest news If you want us to remove your company's earnings call or any other conference call, please reach out to [email protected].

    Watch on YouTube ↗

  • Challenges and Opportunities in Xenotransplantation (Dr. Gordon, Dr. Curtis & Dr. Peterson)

    October 21, 2025 · 📺 American Association of Kidney Patients

    Session: Challenges and Opportunities in Xenotransplantation Moderator: Edward V. Hickey, III, USMC Veteran, AAKP President; Chair, AAKP Veterans Health Initiative; caregiver; current chronic kidney disease patient (Virginia) Speakers: • Elisa J. Gordon, PhD, MPH, Professor, Department of Surgery, and Center for Biomedical Ethics and Society, Vanderbilt University Medical Center (Tennessee) • Mike Curtis, PhD; President and CEO, eGenesis (Massachusetts) • Leigh Peterson, PhD; Executive Vice President of Product Development & Xenotransplantation, United Therapeutics Corporation (Maryland)…

    Watch on YouTube ↗

  • United Therapeutics - TYVASO® (treprostinil) INCREASE Study Data

    February 20, 2021 · 📺 HPR

    Dr. Leigh Peterson, Ph.D., Vice President of Product Development at United Therapeutics discusses data published in the "New England Journal of Medicine" (Jan 2021) on the INCREASE study evaluating Tyvaso in pulmonary hypertension associated with interstitial lung disease (PH-ILD). The INCREASE study is the first to demonstrate a clear benefit in patients with PH-ILD, a life-threatening disease with no currently FDA-approved treatments. She talks about what's next for Tyvaso as they look to achieve FDA approval. #INCREASEStudy #TYVASO #UnitedTherapeutics Leigh Peterson: In her role as Vice…

    Watch on YouTube ↗

Other executives at United Therapeutics

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →